Form 4: Cencora Director Acquires Shares as Compensation

Cencora Director Dennis M. Nally acquired 122 shares of common stock as part of his compensation, bringing his total beneficial ownership to 13,373 restricted stock units.

Summary

• Director Dennis M. Nally acquired 122 shares of Cencora, Inc. common stock on August 1, 2025.
• The shares were acquired at a price of $288.35 per share.
• This acquisition was in lieu of a $35,000 quarterly cash retainer, as per the company's Non-Employee Director Compensation Program.
• Following this transaction, Dennis M. Nally's beneficial ownership stands at 13,373 shares.
• These 13,373 shares are identified as annual grants of restricted stock units (RSUs), received for no consideration, and are set to vest 100% on the first anniversary of their grant date.

Sentiment

Score: 6

Explanation: Slightly positive due to director acquiring shares, indicating alignment of interests, but it's a routine compensation event rather than a discretionary purchase.

Positives

• Director acquiring shares indicates alignment of interests with shareholders.
• The acquisition of shares in lieu of a cash retainer demonstrates commitment to the company's equity.

Risks

• The vesting of restricted stock units (13,373 shares) on the first anniversary of the grant date introduces a future liquidity event for the director, which could potentially lead to sales.

Future Outlook

The 13,373 restricted stock units are set to vest 100% on the first anniversary of their grant date, indicating a future liquidity event for the director.

Industry Context

This filing is a standard insider transaction disclosure and does not provide broader industry context or trends. It reflects a routine compensation practice for non-employee directors.

Comparison to Industry Standards

• The practice of compensating non-employee directors with equity (shares or RSUs) in lieu of or in addition to cash is a common corporate governance practice across industries, aligning director interests with shareholders.
• The specific value of the retainer ($35,000 quarterly) and the share price ($288.35) are specific to Cencora, Inc. and would need comparison with peer companies in the pharmaceutical distribution or healthcare services sector (e.g., Cardinal Health, McKesson) to assess if the compensation structure or share valuation is in line with industry standards.

Corporate Governance

Stakeholder Impact

• Shareholders: Director's increased equity stake aligns interests with shareholders.

Next Steps

• The 13,373 restricted stock units will vest 100% on the first anniversary of their grant date.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary acquisition of shares by a director as part of their compensation. It does not provide new financial performance data, strategic shifts, or significant market-moving information that would warrant a change in investment recommendation. The transaction itself is a positive signal of alignment but is not substantial enough to alter the fundamental investment thesis for Cencora, Inc.

Keywords

Cencora, COR, Dennis Nally, SEC Form 4, Insider Trading, Director Compensation, Stock Acquisition, Restricted Stock Units, Equity Compensation